Enphase Energy【E2NP34】銘柄情報 | ADVFN

US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
ブラジル
BOV
Enphase Energy Inc (E2NP34) 銘柄情報

Enphase Energy Inc (E2NP34)

18.04

0.66

(3.80%)

終了 12月18日 5:55AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

18.04

買値

17.33

売値

18.80

出来高

376

17.82 日の範囲 18.46

12.88 52 週間の範囲 30.56

時価総額

前日終値

17.38

始値

18.46

時刻

最終取引時間

財務取引量

R$ 6,747

VWAP

17.943

平均取引量 (3 か月)

1,402

発行済株式数

136,551,000

配当利回り

-

PER

22.83

1 株当たり利益 (EPS)

3.21

歳入

2.29B

純利益

438.94M

セクター

Semiconductor,related Device

業界

Semiconductor,related Device

ウェブサイト

www.enphase.com

本社

Wilmington, Delaware, USA

設立

-

Enphase Energy Inc is listed in the Semiconductor,related Device sector of the ボベスパ (ブラジル) with ticker E2NP34. The last closing price for Enphase Energy was R$17.38. Over the last year, Enphase Energy shares have traded in a share price range of R$ 12.88 to R$ 30.56.

Enphase Energy currently has 136,551,000 shares in issue. The market capitalisation of Enphase Energy is R$2.37 billion. Enphase Energy has a price to earnings ratio (PE ratio) of 22.83.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.6	-3.21888412017	18.64	18.64	17.38	94	17.82309829	DR
4	3.72	25.9776536313	14.32	18.78	14.14	948	16.50533637	DR
12	-7.31	-28.8362919132	25.35	25.35	12.88	1402	17.0472171	DR
26	-8.76	-32.6865671642	26.8	28.4	12.88	780	18.65577459	DR
52	-6.96	-27.84	25	30.56	12.88	667	20.67586714	DR
156	-10.1	-35.8919687278	28.14	71.4	12.88	3716	26.58221433	DR
260	-10.1	-35.8919687278	28.14	71.4	12.88	3716	26.58221433	DR

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ATED3Atom Educacao E Editora S.A.	R$ 2.05 (39.46%)	267.1k
AGXY3Agrogalaxy Participacoes SA	R$ 0.50 (25.00%)	4.74M
DOTZ3Dotz S.A.	R$ 3.20 (18.96%)	68.4k
DASA11Diagnosticos da America S.A	R$ 1.08 (13.68%)	100
IFCM3Infracommerce Caxaas S.A.	R$ 0.09 (12.50%)	9.38M
COCE11Cia Energetica Ceara Coelce	R$ 0.39 (-35.00%)	11.7k
CRPG3TronoxPigmentos do Brasil S.A.	R$ 21.15 (-20.19%)	1.5k
QUAL3Qualicorp Consultoria e Corretora de Seguros S.A.	R$ 1.79 (-17.51%)	11.66M
EPAR3Embpar Participacoes S.A.	R$ 5.65 (-15.67%)	44.5k
AZEV3Azevedo Travassos Sa	R$ 1.07 (-13.71%)	1.29M
HAPV3Hapvida Participacoes Investimento SA	R$ 2.28 (-11.28%)	313.56M
COGN3CognaEducacao SA	R$ 1.09 (1.87%)	80.64M
BBDC4Bco Bradesco Sa	R$ 11.99 (0.756303%)	66.96M
ITSA4Itausa Investimentos Itau SA	R$ 9.04 (0.110742%)	52.07M
ITUB4Itau Unibanco Holding SA	R$ 31.88 (0.536108%)	40.11M

JMoneyHoops

JMoneyHoops 1分前

Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ

dstock07734

dstock07734 1分前

KILLAZILLA

KILLAZILLA 2分前

DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......

gitreal

gitreal 2分前

...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i

flipper44

flipper44 3分前

Those people know we can still see them, right?

awesomed007

awesomed007 3分前

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

awesomed007

awesomed007 3分前

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

Eatatjoes

Eatatjoes 3分前

Paul Malec of Deer Park, NY

fuagf

Yeps, yeps and yeps. Good ones.

NoMoDo

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.

manibiotech

manibiotech 4分前

Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you

1vman

*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔

janice shell

janice shell 5分前

First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so

HappyAlways

HappyAlways 6分前

I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t

TheDane

TheDane 6分前

Not only did it hold but it’s on the way back up.

OnTrack444

OnTrack444 6分前

Might see a dime after the RS!

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!! Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!! GLTY

manibiotech

manibiotech 7分前

Interesting for sure but not conclusive which he repeat every day

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience

FACT-MASTER

FACT-MASTER 8分前

Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i

arizona1

arizona1 9分前

Never trumpers are hilarious and brilliant too.

jimr1717

jimr1717 10分前

“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is

NoMoDo

NoMoDo 11分前

If we don't see a dime, I will be shocked.

Slyhunter

Slyhunter 11分前

I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is

nfrequent

nfrequent 11分前

Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/

XMaster2023

XMaster2023 11分前

Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will

Aroundtown (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約